Any reported adverse effects 6‐12 months after initiating the intervention (long term) · bipolar disorder
Lamotrigine showed no clear difference in any reported adverse effects 6‐12 months after initiating the… compared with placebo (moderate certainty).
1 finding from 1 review
Activities of daily living · people with stroke
1 finding from 1 review
Secondary outcome measure: lower extremity function at the end of · people with stroke
2 findings from 1 review
Muscle strength · people with stroke
2 findings from 1 review
Secondary outcome measure: cognitive abilities at the end of · people with stroke
The review found no eligible studies for this question.
2 findings from 1 review
no estimate extracted
Studies not reported
No studies found
no estimate extracted
Studies not reported
No studies found
Secondary outcome measure: spatial neglect at the end of the intervention period · people with stroke
1 finding from 1 review
Dropouts, adverse events and deaths during intervention phase Numbers of dropouts, adverse events and deaths from all causes · people with stroke
tDCS showed no clear difference in secondary outcome measure: dropouts, adverse events and deaths… compared with any type of active control intervention (moderate certainty).
1 finding from 1 review
Secondary outcome measure: mean upper extremity function at the end of the intervention periodClinical measures of upper extremity function. Scale from: 0 to infinity. · people with stroke
1 finding from 1 review
ADL outcome · people with stroke
The review found no eligible studies for this question.
2 findings from 1 review
Secondary outcome measure: mean upper extremity function at the end of the intervention periodClinical measures of upper extremity function. Scale from: 0 to infinity. · people with stroke
2 findings from 1 review
Secondary outcome measure: lower extremity function at the end of · people with stroke
1 finding from 1 review
Muscle strength · people with stroke
1 finding from 1 review
Secondary outcome measure: cognitive abilities at the end of · people with stroke
1 finding from 1 review
Secondary outcome measure: hemispatial neglect at the end of · people with stroke
1 finding from 1 review
Dropouts, adverse events and deaths during intervention phase Numbers of dropouts, adverse events and deaths from all causes · people with stroke
tDCS showed no clear difference in secondary outcome measure: dropouts, adverse events and deaths… compared with any type of placebo or passive control intervention (moderate certainty).
1 finding from 1 review
Any complication requiring surgical intervention ‐ NRSs ( · women of reproductive age (15 to 49 years) seeking induced abortion
The review found no eligible studies for this question.
2 findings from 1 review
Any pain‐related outcome indicating some improvement · adults with neuropathic pain
1 finding from 1 review
Intervention not reported
Dropout due to any reason (end of intervention) · people with persistent depressive disorder
The intervention showed no clear difference in dropout due to any reason (end of intervention) (low certainty).
1 finding from 1 review
Any re‐intervention · people with hepatosplenic schistosomiasis
It is very uncertain whether surgical portosystemic shunts changes any re‐intervention compared with devascularisation with splenectomy (very low certainty).
1 finding from 1 review
Incidence ratio of any re‐interventions before leaving hospital
Daikenchuto showed no clear difference in incidence ratio of any re‐interventions before leaving hospital compared with control (moderate certainty).
1 finding from 1 review